ALZN
Price
$3.05
Change
-$0.01 (-0.33%)
Updated
Jul 10 closing price
Capitalization
2.45M
ITRM
Price
$1.08
Change
+$0.15 (+16.13%)
Updated
Jul 10 closing price
Capitalization
42.4M
28 days until earnings call
Interact to see
Advertisement

ALZN vs ITRM

Header iconALZN vs ITRM Comparison
Open Charts ALZN vs ITRMBanner chart's image
Alzamend Neuro
Price$3.05
Change-$0.01 (-0.33%)
Volume$167.37K
Capitalization2.45M
Iterum Therapeutics
Price$1.08
Change+$0.15 (+16.13%)
Volume$504.2K
Capitalization42.4M
ALZN vs ITRM Comparison Chart in %
Loading...
ALZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ITRM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALZN vs. ITRM commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALZN is a StrongBuy and ITRM is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (ALZN: $3.05 vs. ITRM: $1.08)
Brand notoriety: ALZN and ITRM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALZN: 7% vs. ITRM: 86%
Market capitalization -- ALZN: $2.45M vs. ITRM: $42.4M
ALZN [@Biotechnology] is valued at $2.45M. ITRM’s [@Biotechnology] market capitalization is $42.4M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALZN’s FA Score shows that 1 FA rating(s) are green whileITRM’s FA Score has 1 green FA rating(s).

  • ALZN’s FA Score: 1 green, 4 red.
  • ITRM’s FA Score: 1 green, 4 red.
According to our system of comparison, ITRM is a better buy in the long-term than ALZN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALZN’s TA Score shows that 2 TA indicator(s) are bullish while ITRM’s TA Score has 6 bullish TA indicator(s).

  • ALZN’s TA Score: 2 bullish, 3 bearish.
  • ITRM’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, ITRM is a better buy in the short-term than ALZN.

Price Growth

ALZN (@Biotechnology) experienced а +3.74% price change this week, while ITRM (@Biotechnology) price change was +12.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10.19%. For the same industry, the average monthly price growth was +16.32%, and the average quarterly price growth was +20.67%.

Reported Earning Dates

ALZN is expected to report earnings on Mar 10, 2025.

ITRM is expected to report earnings on Aug 08, 2025.

Industries' Descriptions

@Biotechnology (+10.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ITRM($42.4M) has a higher market cap than ALZN($2.45M). ITRM YTD gains are higher at: -38.983 vs. ALZN (-70.785). ALZN has higher annual earnings (EBITDA): -4.16M vs. ITRM (-19.12M). ITRM has more cash in the bank: 12.7M vs. ALZN (3.36M). ALZN has less debt than ITRM: ALZN (301K) vs ITRM (32M). ALZN (0) and ITRM (0) have equivalent revenues.
ALZNITRMALZN / ITRM
Capitalization2.45M42.4M6%
EBITDA-4.16M-19.12M22%
Gain YTD-70.785-38.983182%
P/E RatioN/AN/A-
Revenue00-
Total Cash3.36M12.7M26%
Total Debt301K32M1%
FUNDAMENTALS RATINGS
ITRM: Fundamental Ratings
ITRM
OUTLOOK RATING
1..100
64
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALZNITRM
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
78%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
ALZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ITRM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACDC7.870.35
+4.65%
ProFrac Holding Corp
FTHM1.320.01
+0.76%
Fathom Holdings
RY133.290.86
+0.65%
Royal Bank of Canada
NEU734.582.57
+0.35%
NewMarket Corp
SMC24.330.07
+0.29%
Summit Midstream Corporation

ALZN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALZN has been loosely correlated with SRPT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ALZN jumps, then SRPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALZN
1D Price
Change %
ALZN100%
-0.33%
SRPT - ALZN
49%
Loosely correlated
-1.57%
VRAX - ALZN
43%
Loosely correlated
-3.63%
SNSE - ALZN
41%
Loosely correlated
-0.55%
BPMUF - ALZN
36%
Loosely correlated
N/A
SILO - ALZN
33%
Loosely correlated
+1.37%
More